EQ-5D Value Sets: Inventory, Comparative Review and User Guide
Seiten
2010
|
Softcover reprint of hardcover 1st ed. 2007
Springer (Verlag)
978-90-481-7382-2 (ISBN)
Springer (Verlag)
978-90-481-7382-2 (ISBN)
The EQ-5D is widely used in this context and a number of value sets are available for all the health states generated by the EQ-5D descriptive system. Those seeking to apply EQ-5D valuations in economic evaluation want to know about the availability of EQ-5D value sets and how they can obtain them.
Rosalind Rabin, Frank de Charro, Agota Szende 1.1 Purpose of this booklet Governments and healthcare funders worldwide are making increasing use of economic evaluation to inform priority setting in health care. For various reasons, cost benefit analysis is usually rejected in favour of cost-effectiveness or cost-utility analyses, often involving the estimation of the incremental cost per Quality Adjusted Life Year (QALY) gained (Drummond et al, 2005). The estimation of QALYs gained requires valuations for all relevant health states on a scale anchored at 1 = Full health and 0 = Dead. The EQ-5D is widely used in this context and a number of value sets are available for all the health states generated by the EQ-5D descriptive system. These can be readily applied to health outcomes measured as EQ-5D profiles. EQ-5D has become one of the valuation approaches recommended by several reimbursement authorities and academic bodies in European countries (e.g. The Netherlands, Norway, Italy, Hungary, Poland, Portugal, UK), North America (e.g. Canada), and elsewhere (e.g. New Zealand). The EuroQol Group frequently receives requests for advice regarding EQ-5D valuation data. Those seeking to apply EQ-5D valuations in economic evaluation want to know about the availability of EQ-5D value sets and how they can obtain them. They also seek specific guidance about which of the available value sets they should use for their purposes.
Rosalind Rabin, Frank de Charro, Agota Szende 1.1 Purpose of this booklet Governments and healthcare funders worldwide are making increasing use of economic evaluation to inform priority setting in health care. For various reasons, cost benefit analysis is usually rejected in favour of cost-effectiveness or cost-utility analyses, often involving the estimation of the incremental cost per Quality Adjusted Life Year (QALY) gained (Drummond et al, 2005). The estimation of QALYs gained requires valuations for all relevant health states on a scale anchored at 1 = Full health and 0 = Dead. The EQ-5D is widely used in this context and a number of value sets are available for all the health states generated by the EQ-5D descriptive system. These can be readily applied to health outcomes measured as EQ-5D profiles. EQ-5D has become one of the valuation approaches recommended by several reimbursement authorities and academic bodies in European countries (e.g. The Netherlands, Norway, Italy, Hungary, Poland, Portugal, UK), North America (e.g. Canada), and elsewhere (e.g. New Zealand). The EuroQol Group frequently receives requests for advice regarding EQ-5D valuation data. Those seeking to apply EQ-5D valuations in economic evaluation want to know about the availability of EQ-5D value sets and how they can obtain them. They also seek specific guidance about which of the available value sets they should use for their purposes.
Comparative review of Time Trade-Off value sets.- Comparative review of Visual Analogue Scale value sets.- Guidance to users of EQ-5D value sets.
| Erscheint lt. Verlag | 22.11.2010 |
|---|---|
| Reihe/Serie | EuroQol Group Monographs ; 2 |
| Zusatzinfo | XI, 91 p. |
| Verlagsort | Dordrecht |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung |
| ISBN-10 | 90-481-7382-5 / 9048173825 |
| ISBN-13 | 978-90-481-7382-2 / 9789048173822 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
das Manual zur psychologischen Gesundheitsförderung
Buch | Hardcover (2023)
Springer Berlin (Verlag)
CHF 55,95
Orthomolekulare Medizin in Prävention, Diagnostik und Therapie
Buch | Hardcover (2022)
Thieme (Verlag)
CHF 81,80
